04 October 2018
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that it has issued a total of 2,432 ordinary shares of 0.2 pence each ("Ordinary Shares") as a result of the exercise of employee share options, in connection with the Company's SAYE sharesave scheme 2014/2017 (the "SAYE Shares").
The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of 2,432 SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2017.
The Company also announces that 179 Ordinary Shares of 0.2 pence each (the "New Shares") were issued on 03 October 2018 as a result of the exercise of employee share options by a former employee, in connection with the Company's December 2015 - December 2018 (January 2019 Maturity) Save As You Earn Scheme.
Application will be made for the New Shares, which rank pari passu in all respects the with Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 9 October 2018.
Following the issue of the SAYE Shares and the New Shares, the Company's total issued share capital will be 70,373,031 ordinary shares of 0.2 pence each with one voting right per share. The Company does not hold any ordinary shares in Treasury. This figure of 70,373,031 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts: CVS Group plc Simon Innes, Chief Executive Richard Fairman, Chief Finance Officer
|
Tel: 01379 644 288 |
|
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Jen Boorer Ben Farrow |
Tel: 020 7496 3000 |
|
|
|
|